CIMZIA® is a biologic drug that blocks TNF and reduces inflammatory pain. It is used to relieve certain rheumatological, gastroenterological, and dermatological conditions in adults. CIMZIA® should only be used after serious consideration of benefits and risks, as it is a boxed warning drug.
Given its potential side effects, it is even more important for health practitioners to buy CIMZIA® from reliable, licensed distributors. The sales agents at Med Supply Solutions can give you all the guidance you need.
CIMZIA®
0 items
Sort by
Filters
Category
Brand
Price Range
$
$
No products were found matching your selection.
Global Best Sellers
What Is CIMZIA® Used For?
CIMZIA® is used in the treatment of adult patients. It should not be prescribed to pediatric patients. It is used in the treatment of the following conditions:- Moderately to severely active rheumatoid arthritis
- Active psoriatic arthritis
- Active ankylosing spondylitis
- Moderate-to-severe plaque psoriasis in patients who are candidates for phototherapy or systemic therapy
- Active non-radiographic axial spondyloarthritis with objective signs of inflammation
How Long Does CIMZIA® Last?
CIMZIA® is indicated for long-term conditions, so it may require long-term use. Also, it may take time for CIMZIA to start working. The time it takes for patients to notice improvement depends on the underlying condition they are treating:- Plaque psoriasis – 64% of patients with plaque psoriasis saw their skin clear up in 16 weeks. The same patients maintained clear skin for almost one year.
- Crohn’s disease – 64% of clinical trial patients saw results at 6 weeks. 63% of these patients continued to see results, while 48% achieved remission at 26 weeks.
- Rheumatoid arthritis – 59% of patients saw improvement at 24 weeks.
- Psoriatic arthritis – 58% of patients saw symptom reduction within 12 weeks.
- Non-radiographic axial spondyloarthritis – While some patients saw improvement within two weeks, 47% had significant improvement at one year.
- Ankylosing spondylitis – 57% of patients saw improvement at 12 weeks, and some saw improvement at one to two weeks.
CIMZIA® Administration Techniques
CIMZIA® is administered by subcutaneous injection and comes in two variants: a lyophilized powder intended for healthcare facilities and a prefilled syringe for patients to self-inject at home. Healthcare professionals can buy CIMZIA® wholesale to offer it to their patients at more affordable prices.CIMZIA® Side Effects
There have been severe and sometimes adverse effects connected to CIMZIA®. Physicians must weigh the risks and benefits carefully before prescribing the drug to patients. They should also monitor their condition and exclude all contraindications before recommending it. These include serious infections such as:- Tuberculosis
- Bacterial sepsis
- Invasive fungal infections
- Hepatitis B virus reactivation
- Infections by opportunistic pathogens such as Legionella and Listeria
- Parasitic infections
- Hypersensitivity
- Neurologic reactions
- Hematologic reactions
- Malignancies
- Heart Failure
- Autoimmunity
- Immunosuppression
- Lower and upper respiratory tract infections
- Bacterial infections
- Viral infections
- Fever
- Hypertension
- Rash or itching
- Abdominal pain, nausea, vomiting, diarrhea, constipation, pain, distension, heartburn, or indigestion
- Injection site reactions
- Weakness and malaise
- Headaches
- Dizziness
- Hair loss
CIMZIA® vs. Competition
CIMZIA® (certolizumab pegol) has different alternatives depending on the condition. However, there are no biosimilars or medications with the same active ingredients sold under a different brand.Where Can I Buy CIMZIA®?
Healthcare professionals should only do so from reliable sources to ensure a safe and authentic product, especially given the serious side effects that the drug may have. If you want to order CIMZIA® online, speak to one of our agents for more information.Newsletter
Subscribe for exclusive offers and updates on new arrivals
- item.id === nextId);
if(existingIndex !== -1){
toasts.splice(existingIndex, 1);
}
toasts.unshift({
id: nextId,
show: false,
message: event.detail.message,
description: event.detail.description,
type: event.detail.type,
html: event.detail.html,
duration: Number(event.detail.duration || 4000),
persistent: !!event.detail.persistent
});
"
@mouseenter="toastsHovered=true;"
@mouseleave="toastsHovered=false"
x-init="
if(layout == 'expanded'){
expanded = true;
}
stackToasts();
$watch('toastsHovered', function(value){
if(layout == 'default'){
if(position.includes('bottom')){
resetBottom();
} else {
resetTop();
}
if(value){
// calculate the new positions
expanded = true;
if(layout == 'default'){
stackToasts();
}
} else {
if(layout == 'default'){
expanded = false;
setTimeout(function(){
stackToasts();
}, 10)
}
}
}
});
"
class="fixed block w-full group z-99 sm:max-w-lg"
:class="{ 'right-0 top-0 sm:mt-6 sm:mr-6': position=='top-right', 'left-0 top-0 sm:mt-6 sm:ml-6': position=='top-left', 'left-1/2 -translate-x-1/2 top-0 sm:mt-6': position=='top-center', 'right-0 top-0 sm:mr-6 sm:mb-6': position=='bottom-right', 'left-0 bottom-0 sm:ml-6 sm:mb-6': position=='bottom-left', 'left-0 bottom-0 sm:ml-6 sm:mb-6': position=='bottom-center' }"
x-cloak>
-